Procyclidine hydrochloride

Jump to: navigation, search
Procyclidine hydrochloride
File:Procyclidine hydrochloride.png
Clinical data
Routes of
administration
oral, im, iv
ATC code
Pharmacokinetic data
Protein binding~100%-albumin
Elimination half-life~12 h
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H30ClNO
Molar mass323.9 g/mol

WikiDoc Resources for Procyclidine hydrochloride

Articles

Most recent articles on Procyclidine hydrochloride

Most cited articles on Procyclidine hydrochloride

Review articles on Procyclidine hydrochloride

Articles on Procyclidine hydrochloride in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Procyclidine hydrochloride

Images of Procyclidine hydrochloride

Photos of Procyclidine hydrochloride

Podcasts & MP3s on Procyclidine hydrochloride

Videos on Procyclidine hydrochloride

Evidence Based Medicine

Cochrane Collaboration on Procyclidine hydrochloride

Bandolier on Procyclidine hydrochloride

TRIP on Procyclidine hydrochloride

Clinical Trials

Ongoing Trials on Procyclidine hydrochloride at Clinical Trials.gov

Trial results on Procyclidine hydrochloride

Clinical Trials on Procyclidine hydrochloride at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Procyclidine hydrochloride

NICE Guidance on Procyclidine hydrochloride

NHS PRODIGY Guidance

FDA on Procyclidine hydrochloride

CDC on Procyclidine hydrochloride

Books

Books on Procyclidine hydrochloride

News

Procyclidine hydrochloride in the news

Be alerted to news on Procyclidine hydrochloride

News trends on Procyclidine hydrochloride

Commentary

Blogs on Procyclidine hydrochloride

Definitions

Definitions of Procyclidine hydrochloride

Patient Resources / Community

Patient resources on Procyclidine hydrochloride

Discussion groups on Procyclidine hydrochloride

Patient Handouts on Procyclidine hydrochloride

Directions to Hospitals Treating Procyclidine hydrochloride

Risk calculators and risk factors for Procyclidine hydrochloride

Healthcare Provider Resources

Symptoms of Procyclidine hydrochloride

Causes & Risk Factors for Procyclidine hydrochloride

Diagnostic studies for Procyclidine hydrochloride

Treatment of Procyclidine hydrochloride

Continuing Medical Education (CME)

CME Programs on Procyclidine hydrochloride

International

Procyclidine hydrochloride en Espanol

Procyclidine hydrochloride en Francais

Business

Procyclidine hydrochloride in the Marketplace

Patents on Procyclidine hydrochloride

Experimental / Informatics

List of terms related to Procyclidine hydrochloride

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Procyclidine hydrochloride is an anticholinergic drug principally used for the treatment of:

Uses

It is used in patients with schizophrenia to reduce the side effects of antipsychotic treatment, such as parkinsonism and akathisia.

Procyclidine is also a second-line drug for the treatment of Parkinson's disease. It improves tremor but not rigidity or bradykinesia.

Procyclidine is also sometimes used for the treatment of dystonia (but not tardive dyskinesia), a rare disorder that causes abnormal muscle contraction, resulting in twisting postures of limbs, trunk, or face.

Signs of Overdose

Signs of procyclidine overdose are those of an anticholinergic and include confusion, agitation and sleeplessness that can last up to or more than 24 hours. Pupils become dilated and unreactive to light. Tachycardia (fast heart beat), as well as auditory and visual hallucinations have also been reported.

Other known symptoms of overdose are: clumsiness or unsteadiness, being severely drowsy, having a severely dry mouth, nose, or throat, having an altered mood or other mental changes, seizures, being short of breath or having troubled breathing, a dry and warm, flushed skin.

A suspected overdose with severe life-threatening symptoms should immediately be brought to medical attention, where reversal can be attempted with physostigmine administered intravenously or subcutaneously.

References

  • British National Formulary (45 ed.). 2003. Unknown parameter |month= ignored (help)

Linked-in.jpg